After a respite on Thursday, stocks and index ETFs tumbled once again on Friday after a trial result from Johnson & Johnson’s coronavirus vaccine disappointed some investors. Fears about a retail trading battle between smaller and larger investing players continued. The Dow Jones Industrial...